Creative Capital Management Investments LLC Avidity Biosciences, Inc. Transaction History
Creative Capital Management Investments LLC
- $220 Million
- Q3 2024
A detailed history of Creative Capital Management Investments LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Creative Capital Management Investments LLC holds 1,603 shares of RNA stock, worth $49,885. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,603
Previous 1,603
-0.0%
Holding current value
$49,885
Previous $65,000
12.31%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
255Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$331 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$287 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$268 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$253 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$219 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.62B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...